Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of ...

Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

French drugmaker Sanofi plans to invest 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, a ...

SHANGHAI, Dec 2 (Reuters) - Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

Sanofi has made its single largest investment in China to date by pouring roughly €1 billion ($1.05 billion) into a new ...

The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing ...

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

Sanofi SAN0.41%increase; green up pointing triangle plans to spend about $1.05 billion building a new insulin manufacturing base in China, the French company’s largest single investment in the ...